In this episode, Dr. Nilay Chakraborty discusses the newly launched MicroQuant portfolio by ATCC, which consists of quantitated microbial reference materials designed to simplify quality control testing. These materials are essential for ensuring the safety and efficacy of products across various industries, including food, cosmetics, and pharmaceuticals. The portfolio includes 12 products that meet stringent regulatory requirements, focusing on ease of use and delivering consistent results in terms of colony-forming units (CFU). They highlight the importance of regulatory guidelines and how the portfolio addresses both known pathogens and adventitious agents. The conversation emphasizes the engineering innovation behind MicroQuant, which reduces preparation time from two weeks to less than a minute, offering significant cost savings and logistical benefits. The portfolio is designed to reduce genetic drift risks and ensure consistency in QC testing, with potential for future expansion based on customer input.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related